Transforming Care With Patient-Centered focus

Love Lifesciences is advancing care through responsible innovation— learning fast, acting ethically, and delivering solutions that genuinely improve patient lives.

Because Every Dose Matters

Mission:

Revolutionize the patient experience to ensure all patients are given the opportunity to Love Life

UNIPEN injection pens

Our Story

Our Story

2021

Love Lifesciences founded by Nick Love, MD, MBA and Bradley Hopper after witnessing patient non-compliance

2022

Prototype UNIPEN developed;
UNIPEN patents & trademarks filed

2023

ISO, FDA Guidance & Human Factors testing performed on UNIPEN;
Commercial strategy developed & initiated

2024

FDA determination letter received;
APC strategic partnership announced

2025

UniPen Limited Market Release (LMR) launched;
Semi-Automated Tabletop Fill-Finish System developed, patents filed & launched with LMR partner

2026

Official Full Market Launch of UniPen and Tabletop Fill-Finish System

Love Lifesciences' Guiding Pillars

Patient Centric

Every decision starts with the patient, ensuring Love Lifesciences' products measurably enhance their experience and outcomes.

Adapt and Pivot

Agility is in the Love Lifesciences DNA, enabling our team to seize new opportunities and outmaneuver entrenched competitors.

Ethical Business Practices

We conduct all operations with uncompromising integrity, honoring the trust of patients, colleagues, and investors alike.

Rapidly Learn from Success & Failure

We grow faster by rigorously extracting lessons from every win, misstep, and shared experience.

Exceed the Standard

Meeting regulations is the baseline; we intentionally outperform industry benchmarks to deliver superior outcomes and exceptional value.

Innovate in Every Aspect

We embed creative problem-solving across product & business so each challenge results in breakthroughs that amplify impact.

Leadership

Nick Love, MD, MBA

Nick Love, MD, MBA

CEO, Co-Founder

Background in Biopharma Business Analytics & Research
Board Member – BioKansas
Advisory Board Member – KU School of Medicine

Bradley Hopper

Bradley Hopper

CTO, Co-Founder

10y+ founding & growing companies in various industries
Background in Product Design & Engineering

Erik Blume, JD, MBA

Erik Blume, JD, MBA

Chief Operations Officer

10y+ founding, building, and supporting biosciences and deep-tech startups

Sujal Shah

Sujal Shah

Head of Growth Strategy

20y+ in MedTech commercial & market development strategy leadership for Johnson & Johnson, Pfizer

John Ziobro

John Ziobro

Head of Regulatory Affairs

35y+ Medical Device expertise including executive management, engineering, regulatory affairs

Clinical & Scientific Advisory Board

Kyle Gillett, MD

Kyle Gillett, MD

Founder of Gillett Health Medical Spa & Concierge Care
Specializes in Obesity Medicine & Hormone Replacement Therapy

Brian Williamson, PharmD

Brian Williamson, PharmD

Previous Founder & Owner of JCB Laboratories, 503B Pharmacy sold to Fagron

Rick Couldry, PharmD

Rick Couldry, PharmD

Chief Pharmacy Officer / VP of Health Professions at The University of Kansas Health System
Built >$500M ARR Specialty Pharmacy

Selina Gierer, DO

Selina Gierer, DO

Director of Allergy & Immunology at the University of Kansas Health System

Dan Aires, MD, JD

Dan Aires, MD, JD

Prior Director of Division in Dermatology at The University of Kansas Hospital System
CEO & Co-Founder of Kanpecia Biotech

Tom Krol, PharmD

Tom Krol, PharmD

30y+ Experience in Pharma/Biotech including strategy development, drug development

Lisa Friis, PhD

Lisa Friis, PhD

Director of Product Development Core at KU
CTO DirectSync Surgical

COMMERCIAL ADVISORY BOARD

Nancy Forlenza

Nancy Forlenza

20y+ in Pharma Sales Management including startup experience
Launched & sold injectable products including TRT

Jason Andrews

Jason Andrews

CEO at GemTech Manufacturing
Prior Owner/CEO of GroupSource GPO
20y+ in medical device sales

Bryce Davis

Bryce Davis

CEO at Data Insights
CEO at Karte Payments & Managing Partner PayCloud innovations

Dave Van Brunt

Dave Van Brunt

25y+ Experience as Marketing Director & VP of Marketing at GSK and Bayer

Kevin Lockett

Kevin Lockett

Board Member – The University of Kansas Health System and Kansas City University
Managing Partner, Fulcrum Global Capital

Robin Love

Robin Love

20y+ in Pharma/Medical Device Sales Management at J&J, Pfizer, and Novartis
Launched & sold multiple injectable products

backed by a growing Network of more than 130 trusted partners, customers, and supporting organizations

Partner logo Partner logo Cleveco LLC Couponix Partner logo Partner logo Partner logo Partner logo Partner logo Partner logo Prime Label KC Partner logo Made in Kansas

CONTACT US

Reach out to learn more

Contact Us